Barrett Business Svcs Inc SEC Filings

Arteris, Inc. (NASDAQ: AIP) – Form 144 filing discloses that a shareholder intends to sell up to 1,554 common shares through Morgan Stanley Smith Barney on or after 07 / 03 / 2025. The estimated aggregate market value is $14,125.86. Total shares outstanding are 41,977,728, so the proposed sale represents roughly 0.0037 % of shares outstanding.

The filer—identified in the accompanying sales history as “10b5-1 Sales Plan for Laurent Moll” and “Laurent Moll”—has already disposed of 2,368 shares over the past three months through multiple Rule 10b5-1 transactions, generating $16,743 in gross proceeds. Combined with the new notice, total contemplated and recent sales amount to 3,922 shares, or approximately 0.009 % of outstanding shares.

No information on the seller’s relationship to Arteris, the purpose of the sale, or any material, non-public information is provided, and the standard Rule 144 representation affirms the seller’s lack of undisclosed adverse knowledge. Given the de-minimis size relative to the public float, the filing is unlikely to have a material impact on AIP’s share price, but investors may note the continued insider selling trend.

Arteris, Inc. (NASDAQ: AIP) – Form 144 filing discloses that a shareholder intends to sell up to 1,554 common shares through Morgan Stanley Smith Barney on or after 07 / 03 / 2025. The estimated aggregate market value is $14,125.86. Total shares outstanding are 41,977,728, so the proposed sale represents roughly 0.0037 % of shares outstanding.

The filer—identified in the accompanying sales history as “10b5-1 Sales Plan for Laurent Moll” and “Laurent Moll”—has already disposed of 2,368 shares over the past three months through multiple Rule 10b5-1 transactions, generating $16,743 in gross proceeds. Combined with the new notice, total contemplated and recent sales amount to 3,922 shares, or approximately 0.009 % of outstanding shares.

No information on the seller’s relationship to Arteris, the purpose of the sale, or any material, non-public information is provided, and the standard Rule 144 representation affirms the seller’s lack of undisclosed adverse knowledge. Given the de-minimis size relative to the public float, the filing is unlikely to have a material impact on AIP’s share price, but investors may note the continued insider selling trend.

Arteris, Inc. (NASDAQ: AIP) – Form 144 filing discloses that a shareholder intends to sell up to 1,554 common shares through Morgan Stanley Smith Barney on or after 07 / 03 / 2025. The estimated aggregate market value is $14,125.86. Total shares outstanding are 41,977,728, so the proposed sale represents roughly 0.0037 % of shares outstanding.

The filer—identified in the accompanying sales history as “10b5-1 Sales Plan for Laurent Moll” and “Laurent Moll”—has already disposed of 2,368 shares over the past three months through multiple Rule 10b5-1 transactions, generating $16,743 in gross proceeds. Combined with the new notice, total contemplated and recent sales amount to 3,922 shares, or approximately 0.009 % of outstanding shares.

No information on the seller’s relationship to Arteris, the purpose of the sale, or any material, non-public information is provided, and the standard Rule 144 representation affirms the seller’s lack of undisclosed adverse knowledge. Given the de-minimis size relative to the public float, the filing is unlikely to have a material impact on AIP’s share price, but investors may note the continued insider selling trend.

Barrett Business Services Inc. (BBSI) – Form 4 insider filing

Director Mark Steven Finn reported two equity transactions dated 1 July 2025:

• 593 common shares acquired at a conversion price of $0.00 following the vesting of an equal number of restricted stock units (RSUs). Post-transaction direct ownership rises to 14,443 shares.
• 2,344 new RSUs granted (transaction code “A”) that vest in a single tranche on 1 July 2026. Finn now holds 2,344 RSUs outstanding.

No open-market purchases or sales occurred; the activity reflects normal equity incentive plan mechanics. The net change represents less than 0.1 % of BBSI’s ~7.0 million shares outstanding and therefore is not expected to be material for valuation.

Form 144 filed for Joby Aviation, Inc. (JOBY) discloses a proposed insider sale of 7,961 common shares, worth approximately $80,884, through Morgan Stanley Smith Barney on or about 07/03/2025. The seller, Gregory Bowles, acquired the stock as restricted stock units on 07/01/2025 and will transact on the NYSE. JOBY has ≈791.8 million shares outstanding, so the planned sale represents roughly 0.001% of total shares.

The filing also lists prior insider sales by Bowles over the last three months totaling 25,330 shares for gross proceeds of about $169,434, some executed under a Rule 10b5-1 trading plan. While repeated selling can draw investor attention, the absolute and relative amounts are small and do not materially affect JOBY’s float or capital structure.

Form 144 filed for Joby Aviation, Inc. (JOBY) discloses a proposed insider sale of 7,961 common shares, worth approximately $80,884, through Morgan Stanley Smith Barney on or about 07/03/2025. The seller, Gregory Bowles, acquired the stock as restricted stock units on 07/01/2025 and will transact on the NYSE. JOBY has ≈791.8 million shares outstanding, so the planned sale represents roughly 0.001% of total shares.

The filing also lists prior insider sales by Bowles over the last three months totaling 25,330 shares for gross proceeds of about $169,434, some executed under a Rule 10b5-1 trading plan. While repeated selling can draw investor attention, the absolute and relative amounts are small and do not materially affect JOBY’s float or capital structure.

SI-BONE, Inc. (SIBN) has filed a Form 144 disclosing a proposed insider sale of common stock.

The notice covers the planned disposition of 1,695 shares at an aggregate market value of $31,238.85. The transaction is scheduled for on or about 07/03/2025 and will be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange. According to the filing, SI-BONE has 42,614,514 shares outstanding, so the upcoming sale represents less than 0.01% of the float.

The securities being sold were acquired on 07/01/2025 via restricted stock units issued by the company. Payment details are listed as “N/A,” indicating no cash consideration was required at acquisition.

Recent trading activity by the same account is also disclosed. Over the past three months, the filer completed six sales totaling 50,233 shares for approximately $929,583 in gross proceeds. Five of those trades were executed under a Rule 10b5-1 trading plan.

• Shares to be sold: 1,695
• Approximate value: $31,238.85
• Broker: Morgan Stanley Smith Barney LLC, New York
• Outstanding shares: 42,614,514
• Prior 3-month insider sales: 50,233 shares / $929,582.89

The signer of the notice certifies that no undisclosed material adverse information is known and that the trade complies with Rule 10b5-1, underscoring procedural adherence. Given the very small percentage of shares involved, the immediate financial impact appears limited, though the continued pattern of insider selling may draw investor attention.

SI-BONE, Inc. (SIBN) has filed a Form 144 disclosing a proposed insider sale of common stock.

The notice covers the planned disposition of 1,695 shares at an aggregate market value of $31,238.85. The transaction is scheduled for on or about 07/03/2025 and will be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange. According to the filing, SI-BONE has 42,614,514 shares outstanding, so the upcoming sale represents less than 0.01% of the float.

The securities being sold were acquired on 07/01/2025 via restricted stock units issued by the company. Payment details are listed as “N/A,” indicating no cash consideration was required at acquisition.

Recent trading activity by the same account is also disclosed. Over the past three months, the filer completed six sales totaling 50,233 shares for approximately $929,583 in gross proceeds. Five of those trades were executed under a Rule 10b5-1 trading plan.

• Shares to be sold: 1,695
• Approximate value: $31,238.85
• Broker: Morgan Stanley Smith Barney LLC, New York
• Outstanding shares: 42,614,514
• Prior 3-month insider sales: 50,233 shares / $929,582.89

The signer of the notice certifies that no undisclosed material adverse information is known and that the trade complies with Rule 10b5-1, underscoring procedural adherence. Given the very small percentage of shares involved, the immediate financial impact appears limited, though the continued pattern of insider selling may draw investor attention.

Form 144 filed for Datadog, Inc. (DDOG) discloses a planned sale of insider shares under Rule 144.

• Seller & volume: David Obstler intends to sell 15,000 Class A common shares, representing roughly 0.005 % of the 319,498,060 shares outstanding.
• Estimated proceeds: At an aggregate market value of $2.03 million, the transaction is scheduled for 07 July 2025 through broker Morgan Stanley Smith Barney LLC on the NASDAQ.
• Acquisition details: The shares derive from a 07 July 2025 stock-option exercise paid in cash.
• 10b5-1 activity: The filing lists six prior sales in the last three months under a 10b5-1 plan, totaling 105,016 shares and approximately $12.6 million in gross proceeds.

The filing contains the standard certification that the seller possesses no undisclosed material adverse information. There is no indication of new corporate developments, earnings data, or changes to capital structure; the document strictly concerns insider share dispositions.